Antibodies News and Research

RSS

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

On April 8, Celltrion and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 and CD20.

8 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

Research findings change misconception on white blood cell trafficking to spleen

Contrary to prior belief, the white blood cells enter the spleen primarily via vessels in the red pulp. The research results change thoroughly our perception of the spleen producing antibodies vital for the human body.

3 Apr 2019

Study: Most American allergists prescribe under-the-tongue allergy tablets

Allergy shots (subcutaneous immunotherapy or SCIT) have been available for more than 100 years. Allergy tablets (sublingual immunotherapy or SLIT) have been approved by the Food and Drug Administration for use in the United States for four years.

2 Apr 2019

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed marginal zone lymphoma.

1 Apr 2019

EU-funded researchers develop 'nano-vehicle' to deliver life-saving drugs

Despite many successes, modern medicine is still struggling to find effective treatments for serious pathologies such as cancer and neurodegenerative and inflammatory diseases. For Alzheimer’s disease, for example, only 30% of patients respond to therapy whereas for cancers the figure is only 25%.

1 Apr 2019

Designer organelles in living mammalian cells can build synthetic proteins

A research team led by biophysical chemist Professor Edward Lemke has engineered a designer organelle in a living mammalian cell in a new complex biological translation process. The created membraneless organelle can build proteins from natural and synthetic amino acids carrying new functionalities.

30 Mar 2019

Study uncovers details about human immune response to dengue infection

About 40 percent of the global population is at risk for contracting dengue - the most important mosquito-borne viral infection and a close "cousin" of the Zika virus - and yet, no effective treatment or safe licensed vaccine exists.

29 Mar 2019

Producing human protein in CHO-cells can eliminate the need for blood donors

Alpha-1-antitrypsin is a protein produced by the liver. The protein gets secreted to the blood stream, where it circulates the body to protect the lungs.

28 Mar 2019

Nine top companies win 2019 Pittcon Today Excellence Awards for innovative products

Pittcon, the world’s leading conference and exposition for laboratory science, is pleased to announce the selection of nine finalists in the annual Pittcon Today Excellence Awards conducted by CE Communications, the official publishers of Pittcon Today and the Pittcon Buzz.

From Pittcon 27 Mar 2019

Study offers new insights for vaccine development to prevent RSV disease

In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a runny nose, chest congestion and cough.

27 Mar 2019

Scientists identify mechanism of impaired wound healing in diabetes

Researchers at Karolinska Institutet have identified a mechanism that can explain the impaired wound healing in diabetes which can lead to diabetic foot ulcers. The study is published in the scientific journal PNAS, Proceedings of the National Academy of Sciences.

26 Mar 2019

Immune system errors linked to development of childhood leukemia

Genetic mutations that drive the development of a common type of childhood leukemia can be traced back to errors by the immune system during the production of antibodies.

25 Mar 2019

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019.

25 Mar 2019

Treating women with thyroid antibodies with Levothyroxine do not increase live birth rate

Treating women who have thyroid antibodies, but normal thyroid function, with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research from the United Kingdom suggests.

25 Mar 2019

Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons

New research identifies guidelines for prioritizing the treatment of hepatitis C infections in the U.S. prison system, resulting in a significant improvement in health outcomes of incarcerated persons while simultaneously reducing new infections in the society.

22 Mar 2019

KNAUER introduces new Sepapure FPLC columns and media for protein purification tasks

The new Sepapure columns and media represent high-quality alternatives for common protein purification tasks like size-exclusion, affinity and ion-exchange chromatography.

From KNAUER Wissenschaftliche Geräte GmbH 21 Mar 2019

IgG antibodies play unexpected role in atherosclerosis

Researchers at Karolinska Institutet in Sweden have found that type IgG antibodies play an unexpected role in atherosclerosis.

21 Mar 2019

Role of immunological imprinting in elicitation of new antibodies

We are repeatedly exposed to the influenza virus via infections, vaccinations and our communal environments. The annual flu shot is believed to be the best line of defense, and doctors recommend vaccinations every year because the flu virus is in a constant state of adaptation and mutation, rendering older vaccines obsolete.

21 Mar 2019

Pollutants appear to weaken immune system and increase pathogen virulence

Many people view pollutants and pathogens as separate causes of illness. However, recent research indicates that the two can interact, changing how people and animals respond to infectious diseases.

21 Mar 2019

Antibodies News and Research

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

Research findings change misconception on white blood cell trafficking to spleen

Study: Most American allergists prescribe under-the-tongue allergy tablets

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

EU-funded researchers develop 'nano-vehicle' to deliver life-saving drugs

Designer organelles in living mammalian cells can build synthetic proteins

Study uncovers details about human immune response to dengue infection

Producing human protein in CHO-cells can eliminate the need for blood donors

Nine top companies win 2019 Pittcon Today Excellence Awards for innovative products

Study offers new insights for vaccine development to prevent RSV disease

Scientists identify mechanism of impaired wound healing in diabetes

Immune system errors linked to development of childhood leukemia

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

Treating women with thyroid antibodies with Levothyroxine do not increase live birth rate

Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons

KNAUER introduces new Sepapure FPLC columns and media for protein purification tasks

IgG antibodies play unexpected role in atherosclerosis

Role of immunological imprinting in elicitation of new antibodies

Pollutants appear to weaken immune system and increase pathogen virulence

Antibodies eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo